Chemoproteomics reveals novel protein and lipid kinase targets of clinical CDK4/6 inhibitors in lung cancer

類似資料

• Proteome-wide profiling of clinical PARP inhibitors reveals compound-specific secondary targets
  著者:: Knezevic, Claire E., 等
  出版事項: (2016)
• Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells
  著者:: Ctortecka, Claudia, 等
  出版事項: (2018)
• CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell lines
  著者:: Wright, Gabriela M., 等
  出版事項: (2021)
• A Chemoproteomic Method for Profiling Inhibitor-Bound Kinase Complexes
  著者:: Fang, Linglan, 等
  出版事項: (2019)
• Divergent polypharmacology-driven cellular activity of structurally similar multi-kinase inhibitors through cumulative effects on individual targets
  著者:: Sumi, Natalia J., 等
  出版事項: (2019)